definiens: ) are under the indirect control of Angiotech Pharmaceuticals, Inc., ( ) and as such both are Affiliates ( as defined belo w ) of each other ; AND WHEREAS Angiotech owns certain domestic and foreign patent s and patent applications, and has developed know - how, relating to the manufacture and use of CT3 ; AND WHEREAS [COMPANY] desires to receive a license for the u se of certain of such patents, patent applications and know - how, and Angiotech is willing, and has the right, to grant such a license to His togenics ; NOW THEREFORE, in consideration of the mutual promises and agree ments set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Angiodevice and Biomaterials and [COMPANY] ( Angio tech and [COMPANY] shall be individually referred to as and collectively as ) hereby agree as follows : 1